Active BE 0769.816.843Public limited companyOpen bankruptcy

OP2LYSIS DEVELOPMENT

Boulevard de Patience et Beaujonc 3 ·4000 Liège, Belgium· 5 yrs active

Sector: NACE 72101 (72101)

Conclusion Checked

A bankruptcy procedure is open for OP2LYSIS DEVELOPMENT according to publications in the Belgian State Gazette. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Key figures

Active	5 yrs
Locations	1
Publications	4

Bankruptcy probability (12 mo) Checked model v1 · free

Bankruptcy opened

A bankruptcy procedure is already open — a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.

Risk Assessment rule-based

50 / 100

High risk

Components

· Open bankruptcy (+50)

Trust signals 1 signals

Open bankruptcy

Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.

Administrative Flags 0 events

No administrative flags

Financial overview3 NBB filings

Financials being processed

NBB has 3 filing(s) on record for this company — latest fiscal year 2024 (volledig). The annual accounts are being processed.

Filings on record

Fiscal year	Type	Filed	Reference
31-12-2024	volledig	18-06-2025	2025-00155741
31-12-2023	volledig	13-06-2024	2024-00142676
31-12-2022	volledig	28-07-2023	2023-00308319

Directors & mandates2 persons

Role	Name	Tenure	Source
Curator	LAURENT STAS DE RICHELLE RUE CONSTANTIN DE GERLACHE 41, 4000 LIEGE 1	27-10-2025 → present	Belgian State Gazette
Curator	CATHERINE DELBOUILLE AVENUE CONSTANTIN DE GERLACHE 41, 4000 LIEGE 1	27-10-2025 → present	Belgian State Gazette

Legal Structure

NACE primary	72101
Legal form	Public limited company(014)
Incorporation	17-06-2021
Status	Active
Postal code	4000
First BS signal	13-11-2025
Latest BS signal	13-11-2025

Company structure — linked entities2 linked entities

Mandates

Establishment units 1 location

OP2LYSIS DEVELOPMENT

Avenue du Parc Industriel 89, 4041 HerstalSpeur- en ontwikkelingswerk op biotechnologisch gebied

since 20212.319.639.390

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.

Wallonia 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
62042B0366/00B003	Wallonia	1.9 ha	—	—
62064A0220/00G000	Wallonia	8,511 m²	1 · 1,406 m²	12.8 m · 3 fl.

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data — this is not proof of ownership.

Updates 7 events

A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

13-11-2025

Bankruptcy Opening

Tribunal de l’entreprise de Liège, division Liège · OP2LYSIS DEVELOPMENT SA BOULE- VARD DE PATIENCE ET BEAUJON 3, 4000 LIEGE 1 · event 27-10-2025

18-06-2025

NBB filing Annual accounts filed

fiscal year 2024 · volledig

2024

13-06-2024

NBB filing Annual accounts filed

fiscal year 2023 · volledig

17-01-2024

State Gazette act Capital & shares

Gérard INDEKEU

2023

28-07-2023

NBB filing Annual accounts filed

fiscal year 2022 · volledig

2022

29-11-2022

State Gazette act Capital & shares

Gérard INDEKEU

29-11-2022

State Gazette act Registered-office change

Gérard INDEKEU

Lifecycle & Insolvency Signals 1 events

13-11-2025

Bankruptcy Opening

Date: 27-10-2025 · Tribunal de l’entreprise de Liège, division Liège · OP2LYSIS DEVELOPMENT SA BOULE- VARD DE PATIENCE ET BEAUJON 3, 4000 LIEGE 1 · Publications in State Gazette ↗

Time machine — BS events + macro context 2021 — 2026

Macro context

2020-Q2/Q3 COVID lockdown

2022 energy crisis

2023–2024 ECB rate hikes

Legend

Bankruptcy

Interim / reorg

KBO event

Belgisch Staatsblad — acts 3 acts

Capital history · 2

17-01-2024

Capital change

29-11-2022

Capital change

Address history · 1

29-11-2022

Registered-office move

All acts · 3 updated 2 years ago

2024

17-01-2024 Capital increase of €400,000 to €1,461,490 Capital & shares·Gérard INDEKEU

€1.061.490 → €1.461.490

Notary: Gérard INDEKEU · Bruxelles

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1461490.0,
      "delta_eur": 400000.0,
      "before_eur": 1061490.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "OP2LYSIS",
          "share_class": null,
          "liberation_pct": 25.0,
          "contribution_kind": "numeraire",
          "n_shares_subscribed": 650,
          "contribution_amount_eur": 400000.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 650,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 615.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 100000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 300000.0,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-01-17",
    "filing_date": "2024-01-15",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-12-06",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0769.816.843",
    "name_full": "OP2LYSIS DEVELOPMENT",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procuration",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [
    {
      "kbo": "0769.816.843",
      "pct": 100.0,
      "kind": "org",
      "name": "OP2LYSIS DEVELOPMENT",
      "role": "aandeelhouder",
      "n_shares": 2376,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

2022

29-11-2022 Capital increase of €999,990 to €1,061,490 Capital & shares·Gérard INDEKEU

€61.500 → €1.061.490

Notary: Gérard INDEKEU · BruxellesFirm: Gérard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1061490.0,
      "delta_eur": 999990.0,
      "before_eur": 61500.0,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "GAUDIN Christophe",
          "share_class": null,
          "liberation_pct": 25.0,
          "contribution_kind": "numeraire",
          "n_shares_subscribed": 1626,
          "contribution_amount_eur": 999990.0
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 1626,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 615.0
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 249997.5,
      "n_shares_destroyed": null,
      "not_yet_called_eur": 749992.5,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2022-11-29",
    "filing_date": "2022-11-25",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2022-11-15",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2022-11-15"
  },
  "bedrijfsrevisor": {
    "waived": true,
    "firm_kbo": null,
    "firm_name": null,
    "ibr_number": null,
    "mission_type": "none",
    "individual_name": null
  },
  "subject_company": {
    "kbo": "0769.816.843",
    "name_full": "OP2LYSIS DEVELOPMENT",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "GAUDIN Christophe",
      "role": null,
      "n_shares": 1626,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

29-11-2022 Registered office moved within Liège Registered-office change·Gérard INDEKEU

4000 Liège, Avenue du Parc Industriel, 89 → 4000 Liège, Boulevard Patience et Beaujonc, 3, Legia Park

Notary: Gérard INDEKEU · BruxellesFirm: Gérard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "4000 Li\u00E8ge, Boulevard Patience et Beaujonc, 3, Legia Park",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "4000 Li\u00E8ge, Avenue du Parc Industriel, 89",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Avenue du Parc Industriel",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "89",
        "locality_suffix": null
      },
      "effective_date": null,
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "act_body",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "not_specified",
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2022-11-29",
    "filing_date": "2022-11-25",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
    "date": "2022-11-15",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0769.816.843",
    "name_full": "OP2LYSIS DEVELOPMENT",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": "CG HEALTH VALUE",
    "person_name": "Christophe GAUDIN",
    "org_rep_person_name": null,
    "person_role_at_subject": "Pr\u00E9sident"
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "statuts coordonn\u00E9s"
  ]
}

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

AI-generated from Checked data; indicative, not legal or investment advice.

Company registry (CBE) Crossroads Bank

Activities

Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110

Primary activity highlighted.

Names & trade names

Legal nameFR

OP2LYSIS DEVELOPMENT

Registered office

Boulevard de Patience et Beaujonc 3

4000 Liège, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Same NACE

LIVEDROP BE 0784.926.770 · Liège

QUIDDITAS BE 0794.472.362 · Liège

Abscint BE 0749.828.410 · Liège

Amyl Therapeutics BE 0758.775.372 · Liège

BELMA TECHNOLOGIES BE 0640.973.129 · Liège